search

CERULISIN * GTT OTO FL 20ML

  • IBSA FARMACEUTICI ITALIA Srl
  • 020157018

Ear drops indicated for the removal of ear wax.

info_outline View product sheet
Final Price €13.90
Quantity
check_circle Available (24 Items)
48h
  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Drugs Others products at unbeatable price

IBSA FARMACEUTICI ITALIA Srl

Discover all products

CERULISIN * GTT OTO FL 20ML

Therapeutic indications

For the dissolution of earwax and epidermal plugs. In the cleaning dressings of the operating cavities following interventions in the middle ear.

Dosage and method of use

Dosage The usual dose is equal to the contents of the dropper. For hard caps, the instillations are performed 2-3 times a day and the treatment must be continued for 3-5 days in relation to the amount of ear wax to be extracted. Do not exceed the recommended dose. Method of administration Topical use. The contents of a dropper, preferably warmed, is poured, after tilting the head, into the ear canal. The subject should remain in this position for 5-10 minutes. Afterwards, the ear is washed with warm water.

Contraindications

§ Hypersensitivity to the active ingredients. § Middle ear diseases (otitis, perforated eardrum).

Side effects

Prolonged use of CERULISIN can cause sensitization phenomena. Reporting of suspected adverse reactions Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Special warnings

The use of the medicinal product does not involve special precautions. Do not use in cases of perforated eardrum. The use, especially if prolonged, of the medicine can give rise to sensitization phenomena. If this occurs, discontinue treatment and institute appropriate therapy. Do not use the medicine after the expiry date indicated on the package. Report the onset of any undesirable effects not described in the package leaflet, see section 4.8.

Pregnancy and breastfeeding

There are no known harmful effects at normal therapeutic doses.

Expiration and retention

None.

Interactions with other drugs

There are no known interactions between CERULISIN and other drugs.

Overdose

No cases of overdose have been reported.

Active principles

1 ml contains: • active ingredients: dimethylbenzene 46 mg, sweet almond oil 870 mg.

Excipients

Not present

020157018
24 Items